Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

Iftekhar Khan1,2, Steve Morris3, Nora Pashayan3

  • 1Clinical Trials Unit & Department of Health Economics, University of Surrey, Guilford, UK. I.Khan@surrey.ac.uk.

Abstract